drugset / Trial / NCT02597400
Drug-Drug Interaction Study of Glucokinase Activator HMS5552 and Metformin in T2DM
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase 1, open-label, sequential, multiple-dose, drug-drug interaction study of GK activator HMS5552 and metformin in patients with type 2 diabetes mellitus (T2DM).
Timeline
- Start
- 2015-10
- Primary completion
- 2015-10
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dorzagliatin | Small molecule | 50 mg | — |
| Subject | Metformin | Small molecule | 500 mg | — |